表紙
市場調查報告書

遺傳基因放大技術的全球市場:2019年∼2023年

Gene Amplification Technologies Market by Application and Geography - Global Forecast and Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 910731
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
遺傳基因放大技術的全球市場:2019年∼2023年 Gene Amplification Technologies Market by Application and Geography - Global Forecast and Analysis 2019-2023
出版日期: 2019年09月06日內容資訊: 英文 151 Pages
簡介

全球遺傳基因放大技術市場上,基因研究的增加,標的癌症治療的遺傳基因放大技術大幅度的採用,遺傳基因序列測定的低成本等成為成長促進因素,在預測期間內預計將以9%以上的年複合成長率擴大。但,遺傳基因研究及檢驗相關各種法規指南,為了實施遺傳基因放大研究高的專門知識必要條件,及產品回收的增加等要素,可能妨礙在預測期間內遺傳基因放大技術產業的成長。

本報告提供全球遺傳基因放大技術市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2018年∼2023年)
  • 醫療、醫藥品
  • 法醫學及鑑定試驗
  • 農業及食品安全性
  • 其他
  • 市場機會:各應用領域

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • GM作物相關定量分析的增加
  • 等溫DNA放大的出現
  • 消費者的遺傳學中遺傳基因放大套件和化驗需求高漲

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN Group
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31987

About this market

Technavio's gene amplification technologies market analysis considers sales from medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and other applications. Our analysis also considers the sales of gene amplification technologies in Asia, Europe, North America, and ROW. In 2018, the medical and pharmaceutical segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising prevalence of genetic and infectious conditions and the growing need for drug discovery will play a significant role in the medical and pharmaceutical segment to maintain its market position. Also, our global gene amplification technologies market report looks at factors such as increasing genomic research, substantial adoption of gene amplification technologies in targeted cancer therapies, and low cost of genetic sequencing. However, varying regulatory guidelines on genetic research and testing, requirement for high expertise to perform gene amplification studies, and increasing number of product recalls may hamper the growth of the gene amplification technologies industry over the forecast period.

Overview

Adoption of gene amplification kits in targeted cancer therapies is being witnessed due to the increasing demand for alternative treatments to chemotherapy. This is also due to the increase in approvals for targeted gene therapies by regulatory authorities. Thus, the increasing development of such therapies to treat various cancers, such as colorectal, cervical, and breast cancer, is expected to trigger the adoption of gene amplification technologies and lead to the expansion of the global gene amplification technologies market at a CAGR of over 9% during the forecast period.

Rising demand for gene amplification kits and assays in consumer genetics

Genetic testing for the identification of disease risks and paternity is performed by reference laboratories using gene multiplexing techniques that involve the use of gene amplification kits and assays. The rising popularity of relationship testing services, such as ancestry testing and paternity testing, has resulted in the high adoption of consumer genetic services, specifically among the millennial population. The demand for determining the risk of cancers through genetic tests has increased due to the rising mortality rates associated with cancers. This has promoted the use of dedicated gene amplification kits in direct-to-consumer testing for cancer risk analyses. These factors are expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global gene amplification technologies market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global gene amplification technologies market is moderately fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene amplification technologies manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.

Also, the gene amplification technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Medical and pharmaceutical - Market size and forecast 2018-2023
  • Forensic and identity testing - Market size and forecast 2018-2023
  • Agricultural and food safety - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increasing quantitative studies on GM crops
  • Advent of isothermal DNA amplification
  • Rising demand for gene amplification kits and assays in consumer genetics

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN Group
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Application - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by application
  • Exhibit 20: Medical and pharmaceutical - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Medical and pharmaceutical - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Forensic and identity testing - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Forensic and identity testing - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Agricultural and food safety - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Agricultural and food safety - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Market opportunity by application
  • Exhibit 29: Customer landscape
  • Exhibit 30: Market share by geography 2018-2023 (%)
  • Exhibit 31: Geographic comparison
  • Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Key leading countries
  • Exhibit 41: Market opportunity
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Abbott Laboratories - Vendor overview
  • Exhibit 49: Abbott Laboratories - Business segments
  • Exhibit 50: Abbott Laboratories - Organizational developments
  • Exhibit 51: Abbott Laboratories - Geographic focus
  • Exhibit 52: Abbott Laboratories - Segment focus
  • Exhibit 53: Abbott Laboratories - Key offerings
  • Exhibit 54: Agilent Technologies Inc. - Vendor overview
  • Exhibit 55: Agilent Technologies Inc. - Business segments
  • Exhibit 56: Agilent Technologies Inc. - Organizational developments
  • Exhibit 57: Agilent Technologies Inc. - Geographic focus
  • Exhibit 58: Agilent Technologies Inc. - Segment focus
  • Exhibit 59: Agilent Technologies Inc. - Key offerings
  • Exhibit 60: bioMerieux SA - Vendor overview
  • Exhibit 61: bioMerieux SA - Business segments
  • Exhibit 62: bioMerieux SA - Organizational developments
  • Exhibit 63: bioMerieux SA - Geographic focus
  • Exhibit 64: bioMerieux SA - Key offerings
  • Exhibit 65: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 66: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 67: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 68: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 69: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 70: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 71: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 72: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 73: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 74: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 75: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 76: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 77: Merck KGaA - Vendor overview
  • Exhibit 78: Merck KGaA - Business segments
  • Exhibit 79: Merck KGaA - Organizational developments
  • Exhibit 80: Merck KGaA - Geographic focus
  • Exhibit 81: Merck KGaA - Segment focus
  • Exhibit 82: Merck KGaA - Key offerings
  • Exhibit 83: PerkinElmer Inc. - Vendor overview
  • Exhibit 84: PerkinElmer Inc. - Business segments
  • Exhibit 85: PerkinElmer Inc. - Organizational developments
  • Exhibit 86: PerkinElmer Inc. - Geographic focus
  • Exhibit 87: PerkinElmer Inc. - Segment focus
  • Exhibit 88: PerkinElmer Inc. - Key offerings
  • Exhibit 89: QIAGEN Group - Vendor overview
  • Exhibit 90: QIAGEN Group - Product segments
  • Exhibit 91: QIAGEN Group - Organizational developments
  • Exhibit 92: QIAGEN Group - Geographic focus
  • Exhibit 93: QIAGEN Group - Segment focus
  • Exhibit 94: QIAGEN Group - Key offerings
  • Exhibit 95: Siemens Healthineers AG - Vendor overview
  • Exhibit 96: Siemens Healthineers AG - Business segments
  • Exhibit 97: Siemens Healthineers AG - Organizational developments
  • Exhibit 98: Siemens Healthineers AG - Geographic focus
  • Exhibit 99: Siemens Healthineers AG - Segment focus
  • Exhibit 100: Siemens Healthineers AG - Key offerings
  • Exhibit 101: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 102: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 103: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 104: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 105: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 106: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 107: Validation techniques employed for market sizing
  • Exhibit 108: Definition of market positioning of vendors
Back to Top